◀ Back to PLG

PLG — SERPINE2

Text-mined interactions from Literome

Rossignol et al., J Biol Chem 2004 : Protease nexin-1 expressed by transfected cells significantly inhibited the activity of plasmin and tissue-type plasminogen activator via the formation of inhibitory complexes and prevented cell detachment and apoptosis
Onuma et al., Mech Dev 2006 : Protease nexin-1 (PN-1)/glia derived nexin (GDN) is a member of the Serpin ( serine proteinase inhibitor ) family, and can inhibit thrombin, plasmin , and plasminogen activators
Mansilla et al., Arterioscler Thromb Vasc Biol 2008 (Carotid Artery Diseases) : Protease nexin-1 (PN-1) , a serpin constitutively expressed by vascular smooth muscle cells and endothelial cells, inhibits thrombin, plasminogen activators, and plasmin and can thus be expected to play a role in vascular biology
Festoff et al., J Cell Physiol 1991 : Protease nexin I inhibits both tumor cell and myoblast plasminogen activator mediated destruction of extracellular matrix
Lee et al., Reproductive biology and endocrinology : RB&E 2011 : SERPINE2 , an inhibitor of plasminogen activators, is highly expressed in the human endometrium during the secretory phase
Koshimizu et al., J Mol Neurosci 2011 : pGlu-serpinin 's ability to increase levels of PN-1 , a potent inhibitor of plasmin released during inflammatory processes causing cell death, may play a role in protecting cells under adverse pathophysiological conditions
Stevens et al., Agents Actions Suppl 1993 (Arthritis, Experimental) : Since the plasmin/plasminogen cascade may activate latent MMP during cartilage catabolism, we determined if protease nexin-1 (PN-1) , an inhibitor of plasminogen , plasmin, and urokinase could prevent cartilage degradation